Abiopharma

New Form 6-K - Universe Pharmaceuticals INC Filed: 2025-08-26 AccNo: 0001213900-25-080750 Size: 10 KB

Director Hanson Jason David 🟢 acquired 8.5K shares of BullFrog AI Holdings, Inc. (BFRG) Transaction Date: Aug 22, 2025 | Filing ID: 025527

Guardant Health, Inc. - Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Savara Inc. - Savara Announces Participation in Upcoming Investor Healthcare Conferences

Director Murphy-Chutorian Douglas 🟡 adjusted position in 28.6K shares (1 derivative) of Semler Scientific, Inc. (SMLR) at $30.54 ($1.2M) Transaction Date: Aug 25, 2025 | Filing ID: 083070

SmartVest - Electromed, Inc. Announces Record Fiscal 2025 Fourth Quarter and Full Year Financial Results

Pulmonx to Participate in September Investor Conferences

Immuneering Announces Closing of $25 Million Private Placement

Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

Sana Biotechnology to Present at September 2025 Investor Conferences

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences

IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference

Vera Therapeutics to Participate at Upcoming Investor Conferences

Zentalis Pharmaceuticals Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary